![Hans Lennart Rudolf Wigzell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hans Lennart Rudolf Wigzell
Président chez
RAYSEARCH LABORATORIES AB
Fortune : 752 291 $ au 31/05/2026
Profil
Dr. Hans Lennart Rudolf Wigzell is an Independent Director at Sarepta Therapeutics, Inc., a Chairman at RaySearch Laboratories AB, a Chairman at Biochromix Newco AB, a Chairman at PRFA Management AB, a Chairman at Stockholm School of Entrepreneurship, a Member at American Academy of Arts & Sciences, a Member at European Molecular Biology Organization, a Member at Finnish Society of Sciences & Letters, a Member of Royal Danish Academy of Sciences & Letters, a Member at Royal Swedish Academy of Engineering Sciences and a Member at Royal Swedish Academy of Sciences.
He is on the Board of Directors at Sarepta Therapeutics, Inc., Gapminder Foundation, Humabs LLC and Wigzellproduktion AB. Dr. Wigzell was previously employed as an Independent Member-Supervisory Board by Valneva SE, a Member-Supervisory Board by Probi AB, a Chairman by Karolinska Development AB, an Independent Director by Swedish Orphan Biovitrum AB, a Founder by Affibody Medical AB, a President by Karolinska Institutet, a General Director by National Bacteriological Laboratory, a Member-Supervisory Board by Biovitrum AB, a Member-Supervisory Board by Epixis SA, a Chairman by ExThera AB, a Chairman by Rhenman & Partners Asset Management AB, and a General Director by Smittskyddsinstitutet.
He also served on the board at Cadila Pharmaceuticals Sweden AB, Intercell AG, Mertiva AB and NeoDynamics AB. He received his doctorate degree from Karolinska Institutet.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/06/2026 | 42 098 ( 0,04 % ) | 752 291 $ | 31/05/2026 |
Postes actifs de Hans Lennart Rudolf Wigzell
| Sociétés | Poste | Début |
|---|---|---|
| RAYSEARCH LABORATORIES AB | Président | 30/09/2022 |
| SAREPTA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/06/2010 |
Wigzellproduktion AB | Directeur/Membre du Conseil | - |
Biochromix Newco AB | Président | - |
PRFA Management AB | Président | - |
Royal Danish Academy of Sciences & Letters | Corporate Officer/Principal | - |
Stockholm School of Entrepreneurship
 Stockholm School of Entrepreneurship Other Consumer ServicesConsumer Services Functions as a College/University | Président | - |
European Molecular Biology Organization | Corporate Officer/Principal | - |
Finnish Society of Sciences & Letters | Corporate Officer/Principal | - |
| ░░░░░░░░ ░░░░░░░ ░░ ░░░░ ░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Anciens postes connus de Hans Lennart Rudolf Wigzell
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░ ░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Hans Lennart Rudolf Wigzell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
30
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 30 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Intercell AG
 Intercell AG Pharmaceuticals: MajorHealth Technology Manufactures drugs and medicines | Health Technology |
Probi AB
 Probi AB BiotechnologyHealth Technology Develops patents probiotic strains for use in nutritional products | Health Technology |
Mertiva AB
 Mertiva AB Financial ConglomeratesFinance Operates as an investment company | Finance |
Royal Swedish Academy of Sciences
 Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Provides research and development services on sciences | Commercial Services |
RaySearch Laboratories AB
 RaySearch Laboratories AB Packaged SoftwareTechnology Services Supplies computer software that improves the efficacy of radiation therapy for cancer | Technology Services |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services | Health Technology |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
Epixis SA
 Epixis SA BiotechnologyHealth Technology Specializes in the development of advanced immuno-therapies | Health Technology |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services Operates engineering science academy | Commercial Services |
European Molecular Biology Organization | |
Rhenman & Partners Asset Management AB
 Rhenman & Partners Asset Management AB Investment ManagersFinance Rhenman & Partners is an active, long-term, niche manager which follows a long/short strategy focusing exclusively on innovative, fast-growing companies in the healthcare sector. They invest across subsectors, market-caps and geographies to lower volatility. The firm primarily invests in cash flow positive companies which have already received regulatory approval, aiming to mitigate event risk. They construct a diversified portfolio of select positions, roughly allocated equally between small- mid- and large-cap companies. | Finance |
Humabs LLC
 Humabs LLC BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
NeoDynamics AB
 NeoDynamics AB Medical SpecialtiesHealth Technology Develops equipment for diagnosis of breast cancer | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Finnish Society of Sciences & Letters | |
Gapminder Foundation
 Gapminder Foundation Data Processing ServicesTechnology Services Provides data online on trends and statistics | Technology Services |
Smittskyddsinstitutet | |
Royal Danish Academy of Sciences & Letters | |
Karolinska Development AB
 Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Wigzellproduktion AB | |
ExThera AB
 ExThera AB Pharmaceuticals: MajorHealth Technology Manufactures medical products in both in vitro and in vivo studies | Health Technology |
Stockholm School of Entrepreneurship
Stockholm School of Entrepreneurship Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valneva SE
 Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
PRFA Management AB | |
Cadila Pharmaceuticals Sweden AB
 Cadila Pharmaceuticals Sweden AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Biochromix Newco AB | |
National Bacteriological Laboratory |
